May 24, 2017

Pharmaceuticals Consultation Process

Until June 28th 2017, the Patented Medicine Prices Review Board (PMRPB) is conducting public consultations – “Protecting Canadians from Excessive Drug Prices: Consulting on Proposed Amendments to the Patented Medicines Regulations“- on its proposed amendments to the Patented Medicines Regulations.

We have summarized the PMPRB consultation document and written responses to the questions.
Click here to read the Quadra Granville Seniors Group responses to the PMPRB consultation process.

To add your support to our PMPRB responses, please Contact Us. The deadline for adding your support to our responses is June 26, 2017.

To read the entire PMPRB consultation document, click here.